Kirschfink M - Search Results

1

Analysis of the immune status in Latvian Chernobyl clean-up workers with nononcological thyroid diseases.

Kurjane N, Bruvere R, Shitova O, Romanova T, Jaunalksne I, Kirschfink M, Sochnevs A. Kurjane N, et al. Among authors: kirschfink m. Scand J Immunol. 2001 Nov;54(5):528-33. doi: 10.1046/j.1365-3083.2001.00997.x. Scand J Immunol. 2001. PMID: 11696206 Free article.

2

In vitro complement activation by ragweed allergen extract in the sera of ragweed allergic and non-allergic persons.

Hidvégi T, Schmidt B, Varga L, Dervaderics M, Lantos A, Gönczi Z, Barok J, Otos M, Kirschfink M, Späth P, et al. Hidvégi T, et al. Among authors: kirschfink m. Immunol Lett. 1995 Nov;48(1):65-71. doi: 10.1016/0165-2478(95)02445-x. Immunol Lett. 1995. PMID: 8847094 Clinical Trial.

3

Immunological analysis in paediatric HIV patients at different stages of the disease.

Lian YC, Della-Negra M, Rutz R, Ferriani V, de Moraes Vasconcelos D, da Silva Duarte AJ, Kirschfink M, Grumach AS. Lian YC, et al. Among authors: kirschfink m. Scand J Immunol. 2004 Dec;60(6):615-24. doi: 10.1111/j.0300-9475.2004.01492.x. Scand J Immunol. 2004. PMID: 15584973 Free article.

4

Complement analysis in the 21st century.

Mollnes TE, Jokiranta TS, Truedsson L, Nilsson B, Rodriguez de Cordoba S, Kirschfink M. Mollnes TE, et al. Among authors: kirschfink m. Mol Immunol. 2007 Sep;44(16):3838-49. doi: 10.1016/j.molimm.2007.06.150. Mol Immunol. 2007. PMID: 17768101 Review.

5

Are complement deficiencies really rare? Overview on prevalence, clinical importance and modern diagnostic approach.

Grumach AS, Kirschfink M. Grumach AS, et al. Among authors: kirschfink m. Mol Immunol. 2014 Oct;61(2):110-7. doi: 10.1016/j.molimm.2014.06.030. Epub 2014 Jul 15. Mol Immunol. 2014. PMID: 25037634 Review.

6

Complement activation and C3 allotype distribution in patients with bronchial asthma.

Kirschfink M, Castro FF, Rother U, Nakhosteen JA, Deppisch R, Schmitz-Schumann M. Kirschfink M, et al. Int Arch Allergy Immunol. 1993;100(2):151-5. doi: 10.1159/000236402. Int Arch Allergy Immunol. 1993. PMID: 8443468

7

Complement analysis in the era of targeted therapeutics.

Prohászka Z, Kirschfink M, Frazer-Abel A. Prohászka Z, et al. Among authors: kirschfink m. Mol Immunol. 2018 Oct;102:84-88. doi: 10.1016/j.molimm.2018.06.001. Epub 2018 Jun 20. Mol Immunol. 2018. PMID: 29933889 Review.

8

Complement resistance of tumor cells: basal and induced mechanisms.

Jurianz K, Ziegler S, Garcia-Schüler H, Kraus S, Bohana-Kashtan O, Fishelson Z, Kirschfink M. Jurianz K, et al. Among authors: kirschfink m. Mol Immunol. 1999 Sep-Oct;36(13-14):929-39. doi: 10.1016/s0161-5890(99)00115-7. Mol Immunol. 1999. PMID: 10698347 Review.

9

Complement profile in neonates of different gestational ages.

Grumach AS, Ceccon ME, Rutz R, Fertig A, Kirschfink M. Grumach AS, et al. Among authors: kirschfink m. Scand J Immunol. 2014 Apr;79(4):276-81. doi: 10.1111/sji.12154. Scand J Immunol. 2014. PMID: 24460650 Free article.

10

Neutrophil priming by cytokines and vitamin D binding protein (Gc-globulin): impact on C5a-mediated chemotaxis, degranulation and respiratory burst.

Binder R, Kress A, Kan G, Herrmann K, Kirschfink M. Binder R, et al. Among authors: kirschfink m. Mol Immunol. 1999 Sep-Oct;36(13-14):885-92. doi: 10.1016/s0161-5890(99)00110-8. Mol Immunol. 1999. PMID: 10698343 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

199 results

Search Page